SCHEMBL4763757

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL4762734	0.94	HSP90AA1 (0.34)	TGFBR1EEDSUZ12EZH2KMT2A
	SCHEMBL4771564	0.92	TGFBR1 (0.32)	TGFBR1
	SCHEMBL4765439	0.91	NTRK1 (0.31)	TGFBR1
	SCHEMBL5256607	0.87	TGFBR1 (0.33)	TGFBR1KMT2A
	SCHEMBL4764134	0.86	TGFBR1 (0.30)	TGFBR1
	SCHEMBL4770055	0.86	—	—
	SCHEMBL5255949	0.86	TGFBR1 (0.32)	TGFBR1
	Adipiplon SCHEMBL4543571	0.86	—	—
	SCHEMBL4762550	0.85	AXL (0.30)	—
	SCHEMBL5258782	0.85	TGFBR1 (0.31)	TGFBR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.